Diabetes Care Devices - South Africa

In South Africa, revenue in the Diabetes Care Devices market market is projected to reach US$129.10m in 2024.
The revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 11.27%.
This growth will result in a market volume of US$220.30m by 2029.
In a global context, the majority of revenue will be generated the United States, which is expected to reach US$11.71bn in 2024.
In South Africa, the growing prevalence of diabetes is driving innovation and demand for advanced diabetes care devices, enhancing patient management and outcomes.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in South Africa is witnessing considerable growth, fueled by increasing diabetes prevalence, technological advancements in monitoring devices, and a growing emphasis on preventive healthcare among consumers. This trend is reshaping the medical landscape.

Customer preferences: In South Africa, there is a notable shift towards personalized diabetes management solutions, as consumers increasingly prioritize tailored healthcare options that align with their individual lifestyles and cultural contexts. The rise of mobile health applications and advanced glucose monitoring devices reflects a growing preference for technology that offers real-time data and insights. Additionally, a heightened awareness of health and wellness, particularly among younger demographics, is prompting more proactive engagement in diabetes care, transforming traditional treatment approaches into comprehensive self-management strategies.

Trends in the market: In South Africa, the Diabetes Care Devices Market is experiencing a significant shift towards smart glucose monitoring technologies, with an increasing adoption of continuous glucose monitors (CGMs) among patients. The integration of mobile health applications into diabetes management is enhancing patient engagement, allowing for real-time data sharing with healthcare providers. Additionally, a rise in community-based education initiatives is empowering individuals to take control of their health. These trends indicate a move towards more holistic and personalized care strategies, presenting opportunities for industry stakeholders to innovate and collaborate in developing user-centric solutions that cater to diverse patient needs.

Local special circumstances: In South Africa, the Diabetes Care Devices Market is shaped by a unique interplay of factors, including a diverse population with varying access to healthcare and a significant burden of non-communicable diseases. The high prevalence of diabetes in urban areas contrasts with limited resources in rural regions, driving demand for affordable and accessible solutions. Cultural attitudes towards health and wellness also influence patient engagement, with community health initiatives fostering awareness. Additionally, regulatory frameworks that support innovation while ensuring safety are crucial in facilitating the adoption of advanced diabetes management technologies.

Underlying macroeconomic factors: The Diabetes Care Devices Market in South Africa is significantly shaped by macroeconomic factors, including the national economic health and the global economic landscape. Economic stability and growth foster investment in healthcare infrastructure, enabling the development and distribution of advanced diabetes management devices. Additionally, fiscal policies that prioritize healthcare spending can enhance access to these technologies, particularly in underserved areas. The rising burden of diabetes, coupled with increasing awareness and demand for effective management solutions, drives market growth. Furthermore, global trends in medical technology innovation and collaborative efforts in healthcare enhance the availability of affordable diabetes care devices, addressing regional disparities.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.